[Evaluation in children of the clinical, biological and electroencephalographic side effects of L-asparaginase].
D000293:Adolescent; D001215:Asparaginase / Q000009:adverse effects*; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D001921:Brain / Q000187:drug effects*; D056486:Chemical and Drug Induced Liver Injury; D002648:Child; D002675:Child, Preschool; D003920:Diabetes Mellitus / Q000139:chemically induced; D004342:Drug Hypersensitivity; D004569:Electroencephalography; D005334:Fever / Q000139:chemically induced; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D007223:Infant; D007668:Kidney / Q000187:drug effects; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008099:Liver / Q000187:drug effects; D009132:Muscles / Q000187:drug effects; D010179:Pancreas / Q000187:drug effects; D010195:Pancreatitis / Q000139:chemically induced; D013921:Thrombocytopenia / Q000139:chemically induced
D001215:Asparaginase
Evaluation, chez l'enfant, des effets secondaires cliniques, biologiques et électro-encéphalographiques de la L-asparaginase